Tablet Citalopram 40 mg/day plus Tablet placebo as control group for 6 weeks

2 trials

Sponsors

Tehran University of Medical Sciences

Conditions

Major Depressive episode. Major Depressive episode

Phase 3

Scoploamine in the treatment of major depression

Active, not recruitingIRCT201201181556N31

Tehran University of Medical SciencesMajor Depressive episode. Major Depressive episode

Start: 2011-11-10Target: 40Updated: 2018-02-22

Riluzole in the treatment of major depression

Active, not recruitingIRCT201307181556N54

Tehran University of Medical SciencesMajor Depressive episode. Major Depressive episode

Start: 2013-08-23Target: 40Updated: 2018-02-22

Related Papers

Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.

2012-10-1663 citations